Signifor LAR 30 MG and 40 MG

Ended Awarded

Contract number
36C24524N0797
Awardee
Awarding agency
Obligated
$21,622

Award facts

Contract value 100% obligated
$21,622.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of Signifor LAR (pasireotide) 30 mg and 40 mg to the U.S. Department of Veterans Affairs (VA). The contract, valued at $21,622.48, was awarded to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer that specializes in rare disease treatments.

The contract is a delivery order placed against Recordati's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's specialized orphan drug offerings. Additionally, Recordati holds a Blanket Purchase Agreement (BPA) with the VA for several of its rare disease medications, including Signifor, Carbaglu, Cystadane, Isturisa, and Cystadrops. These contracting vehicles provide a streamlined mechanism for VA facilities nationwide to access Recordati's critical pharmaceutical products. The contract does not have a set-aside designation, reflecting the specialized nature of the products being supplied.

Quick answers

Who was awarded contract 36C24524N0797?

36C24524N0797 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 5, 2024.

How much is contract 36C24524N0797 worth?

The government has obligated $21,622 on 36C24524N0797.

Is contract 36C24524N0797 an order under another contract?

Yes. 36C24524N0797 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0797 competed?

The extent of competition for 36C24524N0797 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award